NET PROFIT (x1000 SEK)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
238
|
535
|
58 |
Earnings before taxes |
-45,800
|
-58,372
|
-49,825 |
EBITDA |
-46,484
|
-57,886
|
-49,782 |
Total assets |
44,047
|
51,005
|
56,804 |
Current assets |
38,710
|
44,120
|
55,858 |
Current liabilities |
10,380
|
12,062
|
9,904 |
Equity capital |
30,667
|
34,511
|
46,674 |
- share capital |
1,868
|
1,368
|
1,126 |
Employees (average) |
8
|
9
|
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
69.6%
|
67.7%
|
82.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-103.4%
|
-113.4%
|
-87.6% |
Current ratio |
372.9%
|
365.8%
|
564.0% |
Return on equity (ROE) |
-149.3%
|
-169.1%
|
-106.8% |
Change turnover |
0
![]() |
0
|
-6,725 |
Change turnover % | -100% | ||
Chg. No. of employees |
-1
|
1
|
-2 |
Chg. No. of employees % |
-11%
|
13%
|
-20% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.